A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety ...

Screening individuals for lung cancer with low-dose CT on a nonrisk basis is associated with a marked reduction in lung cancer mortality and better overall survival, reveals Chinese data.

NEW YORK CITY, NY / ACCESS Newswire / March 27, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valneva SE ("Valneva" or "the Company") ...

Data are beginning to provide a clearer picture of chimeric antigen receptor T-cell therapy’s benefits and risks in lupus, ...

It’s rare to get such a massive high-yielder that’s also positioning itself for long-term growth. Of course, shares of Pfizer ...

Dr. Todd Ellerin of South Shore Health discusses the experimental Lyme disease vaccine that will go in front of the FDA.

Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or ...

The U.S. Food and Drug Administration (“FDA”) accepted Celcuity’s New Drug Application (“NDA”) and granted Priority Review with a Prescription Drug User Fee Act (“PDUFA”) goal date of July 17, 2026, f ...

In a multicenter study, researchers at Mass General Brigham found that exchange transfusion was associated with markedly improved outcomes compared ...

A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a ...

High-flying Samsung Biologics is facing a rare bit of public turbulence after the CDMO’s labor union secured the votes needed to strike, signaling a potential escalation in an impasse over what the | ...

Announced in June, positive topline results from registrational STAAR study in Fabry disease, including positive mean annualized estimated ...